PROCARTA BIOSYSTEMS LTD has a total of 46 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2007. It filed its patents most often in United Kingdom, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SANOFI PASTEUR BIOLOGICS CO, PAXVAX INC and ROGOSIN INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 4 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Brazil | 2 | |
#9 | Israel | 2 | |
#10 | Japan | 2 | |
#11 | Mexico | 2 | |
#12 | New Zealand | 2 | |
#13 | Singapore | 2 | |
#14 | South Africa | 2 | |
#15 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Mcarthur Michael | 31 |
#2 | Moore Jane Marion | 10 |
#3 | Michael Mcarthur | 5 |
#4 | Jane Marion Moore | 3 |
#5 | Ltd Mcarthur Michael C O Procarta Biosystems | 1 |
Publication | Filing date | Title |
---|---|---|
GB201906688D0 | Composition | |
GB201814494D0 | Compounds | |
GB201721845D0 | Compounds | |
WO2014140581A1 | Transcription factor decoys | |
US2014274800A1 | Transcription factor decoys for the treatment and prevention of infections caused by bacteria including clostridium difficile | |
GB201304535D0 | Transcription factor decoys | |
GB201005545D0 | Transcription factor decoys | |
GB201002413D0 | Nucleic acid complexes | |
SG191684A1 | Transcription factor decoys | |
GB0719367D0 | Transcription factor decoys, compositions and methods |